- Previous Close
20.25 - Open
20.08 - Bid 19.44 x 100
- Ask 19.53 x 100
- Day's Range
19.17 - 20.08 - 52 Week Range
9.93 - 21.48 - Volume
240,585 - Avg. Volume
392,116 - Market Cap (intraday)
1.132B - Beta (5Y Monthly) 0.94
- PE Ratio (TTM)
14.54 - EPS (TTM)
1.34 - Earnings Date Feb 7, 2025 - Feb 11, 2025
- Forward Dividend & Yield 0.60 (4.16%)
- Ex-Dividend Date Aug 27, 2024
- 1y Target Est
21.05
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
www.embecta.com2,200
Full Time Employees
September 30
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: EMBC
View MorePerformance Overview: EMBC
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EMBC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EMBC
View MoreValuation Measures
Market Cap
1.13B
Enterprise Value
2.47B
Trailing P/E
14.54
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.01
Price/Book (mrq)
--
Enterprise Value/Revenue
2.20
Enterprise Value/EBITDA
12.84
Financial Highlights
Profitability and Income Statement
Profit Margin
6.23%
Return on Assets (ttm)
9.64%
Return on Equity (ttm)
--
Revenue (ttm)
1.12B
Net Income Avi to Common (ttm)
69.7M
Diluted EPS (ttm)
1.34
Balance Sheet and Cash Flow
Total Cash (mrq)
275.1M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
46.59M